Quick Takeaways
- BAILLIE GIFFORD & CO filed SCHEDULE 13G/A for Moderna, Inc. Common Stock (MRNA).
- Disclosed ownership: 10%.
- Date of event: 31 Dec 2024.
BAILLIE GIFFORD & CO - 31 Dec 2024 SCHEDULE 13G/A Report for Moderna, Inc. Common Stock (MRNA)
- Filing Manager
- BAILLIE GIFFORD & CO
- Reporting Manager
- BAILLIE GIFFORD & CO
- Security
- Moderna, Inc. Common Stock
- Symbol
- MRNA
- Shares outstanding
- 385,045,257 shares
- Disclosed Ownership
- 38,889,571 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G/A
- Filing time
- 12 Feb 2025, 09:07:55 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 30 Apr 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BAILLIE GIFFORD & CO disclosed 10% ownership in Moderna, Inc. Common Stock (MRNA) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 Feb 2025, 09:07.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BAILLIE GIFFORD & CO | 10% | 38,889,571 | 31,423,042 | 0 | Grant Meikle | Threshold & Transaction Reporting Manager |